Liver biopsies and methotrexate: A time for reconsideration?
- 31 March 2000
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 42 (3), 531-534
- https://doi.org/10.1016/s0190-9622(00)90237-8
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patientsBritish Journal of Dermatology, 1996
- The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patientsBritish Journal of Dermatology, 1996
- Usefulness of the american college of rheumatology recommendations for liver biopsy in methotrexate‐treated rheumatoid arthritis patientsArthritis & Rheumatism, 1995
- LIVER BIOPSY VERSUS ULTRASOUND IN METHOTREXATE-TREATED PSORIASIS: A DECISION ANALYSISInternational Journal of Dermatology, 1992
- Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: Relation to liver fibrosis and arthritisJournal of the American Academy of Dermatology, 1991
- The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexateBritish Journal of Dermatology, 1988
- Methotrexate in psoriasis: Revised guidelinesJournal of the American Academy of Dermatology, 1988
- A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapyBritish Journal of Dermatology, 1987
- Liver biopsy todayJournal of Hepatology, 1985
- Liver Biopsies in Psoriatics Complications and EvaluationInternational Journal of Dermatology, 1980